A new 2026 treatment algorithm reframes type 2 diabetes care around lifestyle, obesity management, and complications-first decision making rather than glucose alone, embedding structured pathways for prediabetes, classification, and comorbidity-driven drug choice. It adds dedicated algorithms for dyslipidemia, hypertension, obesity pharmacotherapy, and vaccines , and formalizes separate “glucose-centric” vs “complications-centric” tracks to better match therapy with cardiovascular, renal, and obesity risk profiles. The update also pushes clinicians to consider non type 2 diabetes etiologies early and to use visual, stepwise tools to support shared decision-making in routine practice. Explore the new algorithm to stress-test and modernize your current T2D treatment pathways.
To read more Click Here ##Reference## 1. Samson SL, Vellanki P, Blonde L, et al. American Association of Clinical…
